Skip to main content
博迅生物 logo

博迅生物 — Investor Relations & Filings

Ticker · 920504 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 301 across all filing types
Latest filing 2024-03-14 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920504

About 博迅生物

http://www.boxun.com.cn/

Boxun Medical Biological Instrument Corp. specializes in the development and manufacture of laboratory equipment and medical instruments. The company's core product line includes high-pressure steam sterilizers, constant temperature incubators, CO2 incubators, drying ovens, and environmental test chambers. These instruments are designed for applications in life sciences, healthcare, pharmaceutical research, and environmental monitoring. Boxun focuses on delivering precise thermal control and reliable sterilization solutions, ensuring compliance with international quality standards. Its equipment is utilized in scientific research, clinical diagnostics, and industrial quality control to maintain sterile environments and stable experimental conditions. The company emphasizes technical innovation and product durability to support the requirements of modern laboratory facilities.

Recent filings

Filing Released Lang Actions
2024年第一次职工代表大会决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from a company's employee representative meeting, specifically about the election of a new employee representative supervisor to the board of supervisors. It details the meeting date, attendance, agenda, and voting results. There is no financial data, no mention of annual or quarterly reports, no audit information, no earnings release, and no regulatory certifications. The document is an official announcement of a board/management related change (election of a supervisor). Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or a regulatory filing. Confidence is high due to clear content and context.
2024-03-14 Chinese
国金证券股份有限公司关于上海博迅医疗生物仪器股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report from Guojin Securities Co., Ltd. regarding the use of temporarily idle raised funds by Shanghai Boxun Medical Biological Instruments Co., Ltd. It includes specifics about the fundraising, usage, storage, investment products, decision-making process, risk control, and the impact on the company. The document references regulatory approvals, board and supervisory meetings, and includes audit opinions. It is not a brief announcement but a substantive report on the use of raised funds and cash management. This fits the category of a Capital/Financing Update (CAP), as it deals with fundraising proceeds and their management rather than a full annual or interim report, or a simple announcement. The document length (3777 characters) is moderate but contains detailed financial and procedural information about capital usage and management, not just a notice or certification. Therefore, the classification is CAP with high confidence.
2024-03-14 Chinese
关于使用部分暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the use of temporarily idle raised funds for cash management by Shanghai BoXun Medical Biological Instruments Co., Ltd. It details the fundraising amount, usage status, investment products, decision-making process, risk control measures, and opinions from the supervisory board and sponsoring institution. The document does not contain financial statements or detailed financial performance data but is a regulatory disclosure about capital management activities related to fundraising proceeds. It is not an annual report, interim report, earnings release, or any detailed financial report. It fits the category of Capital/Financing Update (CAP) as it updates on the company's fundraising usage and capital management activities.
2024-03-14 Chinese
监事任免公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment and removal of supervisory board members (监事) at Shanghai Boxun Medical Biological Instrument Co., Ltd. It details the nomination, appointment reasons, and resumes of new supervisory members, as well as the impact of these changes on the company's governance structure. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in the company's board or senior management structure. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 1894 characters, which is consistent with a typical management change announcement rather than a full report or regulatory filing.
2024-03-14 Chinese
续聘会计师事务所公告
Audit Report / Information Classification · 90% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (Dahua CPA Firm) for the 2024 audit services of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the firm's background, audit fees, independence, and the board and audit committee's approval of the proposal. There are no actual financial statements or audit reports included, only information about the appointment process and related disclosures. The document length is 3020 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates to audit services and auditor appointment but is not a full annual report or audit report itself. However, given the short length and nature, it could also be considered a Regulatory Filing (RNS), but since it specifically concerns audit firm appointment and audit-related disclosures, AR is more precise. FY 2024
2024-03-14 Chinese
国金证券股份有限公司关于上海博迅医疗生物仪器股份有限公司2023年度募集资金存放与实际使用情况的专项核查报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from Guojin Securities Co., Ltd. regarding the 2023 annual special verification report on the deposit and actual use of raised funds by Shanghai Boxun Medical Biological Instrument Co., Ltd. It includes detailed financial figures about the amount of funds raised, their usage, storage, management, and cash management activities. It also contains auditor's verification opinions and the sponsor's opinions on the compliance and proper use of the funds. The document is focused on the management and use of funds raised through a public stock issuance, which aligns with a specialized audit or verification report on fundraising activities rather than a full annual report or earnings release. The presence of auditor's verification and detailed fund usage confirms it is an Audit Report / Information type document related to fundraising and fund usage verification. The document length (6803 characters) and content confirm it is the report itself, not just an announcement or certification letter. Therefore, the most appropriate classification is Audit Report / Information (AR). FY 2023
2024-03-14 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.